Get started
Author

Chris Ebong

Observed names: C. Ebong, Christopher Ebong, Ebong, Chris
Institution: Ministry of Health
OpenAlex ID: A5062065703
The impact of stopping and starting indoor residual spraying on malaria burden in Uganda
2021 · Jane F. Namuganga, Adrienne Epstein, et al. · Nature Communications · 78
PDF
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
2021 · Chris Ebong, Asadu Sserwanga, et al. · Malaria Journal · 57
PDF
Artemisinin-resistant malaria in Africa demands urgent action
2024 · Mehul Dhorda, Akira Kaneko, et al. · Science · 51
Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis
2021 · Jane F. Namuganga, Jessica Briggs, et al. · Malaria Journal · 34
PDF
Relationships between test positivity rate, total laboratory confirmed cases of malaria, and malaria incidence in high burden settings of Uganda: an ecological analysis
2021 · Jaffer Okiring, Adrienne Epstein, et al. · Malaria Journal · 21
PDF
Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial
2025 · Moses R Kamya, Joaniter I Nankabirwa, et al. · The Lancet Infectious Diseases · 18
East Africa International Center of Excellence for Malaria Research: Impact on Malaria Policy in Uganda
2022 · Jane F. Namuganga, Joaniter I. Nankabirwa, et al. · American Journal of Tropical Medicine and Hygiene · 6
PDF
Availability and the quality of key newborn data within routine health facility data: findings of the IMPULSE observational study in the Central African Republic, Ethiopia, Tanzania, and Uganda
2025 · Rornald Muhumuza Kananura, Dalena Paolo, et al. · Journal of Global Health · 5
Pharmacometric Evaluation of Sulfadoxine-Pyrimethamine-Amodiaquine and Dihydroartemisinin-Piperaquine Seasonal Malaria Chemoprevention in Northern Uganda
2025 · Craig Bonnington, Anthony Nuwa, et al. · Clinical Infectious Diseases · 3
PDF
Efficacies of Artemether-Lumefantrine, Artesunate-Amodiaquine, Dihydroartemisininpiperaquine and Artesunate-Pyronaridine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children in Uganda: A Randomized, Open-Label Phase IV Clinical Trial
2025 · Moses R. Kamya, Joaniter I. Nankabirwa, et al. · SSRN Electronic Journal · 3
Evaluating the public health impact of digital health technologies: A case study of FamilyConnect for maternal and child health in Uganda
2025 · Simon Ndira, Angelica Kiwummulo, et al. · Digital Health · 2
Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
2022 · Chris Ebong, Asadu Sserwanga, et al. · Malaria Journal · 2
PDF
Temporal and spatial trends of low birth weight and Kangaroo Mother Care initiation in Uganda, 2015–2023
2026 · Emmanuel Mfitundinda, Richard Migisha, et al. · Journal of Interventional Epidemiology and Public Health · 1
Stillbirth and newborn data quality and use and related input and process factors: findings of the IMPULSE study in Uganda
2026 · Ronald Wasswa, Lorenzo Giovanni Cora, et al. · Journal of Global Health
Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda
2025 · C. Bonnington, A. Nuwa, et al. · medRxiv
PDF
Additional file 1 of Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
2021 · Ebong, Chris, Sserwanga, Asadu, et al. · Figshare
Works count: 16
Citation count: 281
H-index: 6
I10-index: 6
Year
Topic
Type